Corengi Launches New Web Site to Help Type 2 Diabetes Patients Find SuitableClinical Trials
www.corengi.com simplifies the clinical trial selection process; enables type 2 diabetes patients tolearn which trials are right for them.
Seattle, WA, October 28, 2010 --(PR.com)-- Corengi, Inc. today announced it has launched a new website - www.corengi.com - to help type 2 diabetes patients find clinical trials. The free online tool askspatients a few simple questions about their condition, including weight, blood sugar, and medications, tohelp them identify which ongoing clinical trials may be appropriate for them. According to the Center forDisease Control and Prevention, 23.6 million Americans (or 7.8 percent of the population) have diabetes,of which between 90 and 95 percent have type 2. Currently, the main online sources of type 2 diabetesclinical trial information are either incomplete, confusing, or both. With its comprehensive listing of allongoing type 2 diabetes clinical trials in the U.S. (almost 400, 115 of which were launched since early2010), Corengi simplifies the process of clinical trial selection for patients, and helps them quicklyunderstand which clinical trials might be suitable.A patient will only qualify to participate in a small percentage of these trials. Corengi gathers answers toa set of key questions needed to identify which clinical trials are appropriate for each patient and matchespatients with the right clinical trial options.“We recently surveyed 145 diabetes patients who had previously participated in a clinical trial,” explainsRyan Luce, co-founder of Corengi. “The vast majority of respondents (88 percent) indicated that theywould recommend other diabetes patients to look into clinical trials. Corengi hopes to provide a simpleway for type 2 diabetes patients to explore that option further.”The American Diabetes Association endorses the multiple benefits of clinical trials: “A trial might be theonly way to obtain a new cutting-edge drug or procedure, and patients on trials often receive free expertadvice about taking care of their diabetes. Finally, there is the satisfaction of knowing that because of your efforts, we will better understand diabetes, and you will have contributed in a real way to makingdiabetes a thing of the past.” (source:http://www.diabetes.org/news-research/research/clinical-trials/participation-in-clinical-research.html)About Corengi, Inc.Headquartered in Seattle, WA, Corengi was founded in 2010 by healthcare industry veteran Ryan Luceand seasoned web entrepreneur Elliot Cohen. Corengi is dedicated to helping individuals discover moreabout clinical trials that may be appropriate for them, and committed to building a free, comprehensive,and interactive platform for a variety of diseases. This online platform will allow stakeholders within theclinical trials community, including investigators, site personnel, sponsors, and disease advocates, toengage with potential enrollees and educate them about specific clinical trials. For more information, visitus online atwww.corengi.com.###